Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Patient-derived organoids to investigate drug response and treatment resistance mechanisms in urological cancers

Dr Clémentine Le Magnen, Department of Biomedicine, University of Basel, Switzerland

Friday, 07 March 2025, 11am to 12pm

Oncology Seminar Room, 71a, Old Road Campus Research Building

Refreshments will be available from 10:30am with lunch from 12pm

Biography

Dr. Clémentine Le Magnen

 

Dr Clémentine Le Magnen is leading the laboratory for Translational Genitourinary Cancer Research (TGCR), a joined venture between the Department of Urology and the Institute of Pathology at the University Hospital Basel. Dr Le Magnen and her team are committed to refining our understanding of urological cancers such as prostate cancer and bladder cancer, in an effort to improve management and intervention of these diseases. The research in Dr Le Magnen’s team particularly focuses on the generation of patient-derived models as a tool to study mechanisms driving cancer progression and treatment resistance.

 

 All welcome to attend the lecture and lunch. Kindly register by 12pm on Wednesday 5 March 2025.

 Contact: tarryn.ching@nds.ox.ac.uk